234 related articles for article (PubMed ID: 10934603)
1. [Bisphosphonates in pharmacotherapy of bone diseases].
Iur'ieva EA; Matkovskaia TA; Elagina IA; Stoliarov IuIu
Eksp Klin Farmakol; 2000; 63(3):74-9. PubMed ID: 10934603
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of disorders of mineral metabolism.
Singer FR; Minoofar PN
Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of the bisphosphonates.
Fleisch H
Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358
[TBL] [Abstract][Full Text] [Related]
4. [Perspectives on therapy with diphosphonates in non-malignant diseases].
Willvonseder R; Resch H
Z Gerontol; 1990; 23(1):39-42. PubMed ID: 2183510
[TBL] [Abstract][Full Text] [Related]
5. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
Chapurlat R; Meunier PJ
Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
[TBL] [Abstract][Full Text] [Related]
6. [Development of bisphosphonates].
Nakatsuka K
Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211
[TBL] [Abstract][Full Text] [Related]
7. Experimental basis for the use of bisphosphonates in Paget's disease of bone.
Fleisch H
Clin Orthop Relat Res; 1987 Apr; (217):72-8. PubMed ID: 3549097
[TBL] [Abstract][Full Text] [Related]
8. [Diphosphonates. Current trends and therapeutic prospects].
Raviolo P; Galvagno G; Biarese V; Lovisetto P
Clin Ter; 1989 Apr; 129(1):31-41. PubMed ID: 2525450
[TBL] [Abstract][Full Text] [Related]
9. [The successful development of bisphosphonates in the therapy of osteoporosis].
Fassbender WJ; Stumpf UC; Kurth A
Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
[TBL] [Abstract][Full Text] [Related]
10. [Effects of bisphosphonates in arthroplasty].
Brankamp J; Eberhardt C; Landgräber S; von Knoch M; Saxler G; Löer F; Kurth AA
Z Orthop Ihre Grenzgeb; 2006; 144(2):187-91. PubMed ID: 16625449
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates: mode of action and pharmacology.
Russell RG
Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
[TBL] [Abstract][Full Text] [Related]
13. [How do bisphosphonates improve bone quality?].
Takeuchi Y
Clin Calcium; 2004 Apr; 14(4):627-31. PubMed ID: 15577022
[TBL] [Abstract][Full Text] [Related]
14. [Bisphosphonates. A neu therapy principle in calcium and bone metabolism disorders].
Raue F
Internist (Berl); 1999 Apr; 40(4):448-55. PubMed ID: 10354947
[No Abstract] [Full Text] [Related]
15. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue.
Toussaint ND; Elder GJ; Kerr PG
Clin J Am Soc Nephrol; 2009 Jan; 4(1):221-33. PubMed ID: 18987295
[TBL] [Abstract][Full Text] [Related]
16. [Bisphosphonates: indications in bone diseases other than osteoporosis].
Abdelmoula LC; Ben M'barek R; Ben Hadj Yahia C; Tekaya R; Testouri N; Chaabouni L; Zouari R
Tunis Med; 2011 Jun; 89(6):511-6. PubMed ID: 21681711
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
18. The treatment of osteoporosis. Antiresorptive therapy.
Miller PD
Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
[TBL] [Abstract][Full Text] [Related]
19. Neridronic acid for the treatment of bone metabolic diseases.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Adami S
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1305-11. PubMed ID: 19761412
[TBL] [Abstract][Full Text] [Related]
20. [Mechanisms for anti-resorptive action of bisphosphonates in bone diseases].
Bałczewska E; Bałczewski P
Postepy Biochem; 2001; 47(4):328-36. PubMed ID: 12046265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
